• CytoSorbents will present CytoSorb data at the EACTS Annual Meeting in Barcelona, Oct. 7-10, 2026.
• Additional CytoSorb data will be presented at the ESICM LIVES Annual Congress in Lisbon, Oct. 10-14, 2026.
• Focus areas include cardiac surgery bleeding risk, ECMO-related hyperinflammation, sepsis, septic shock, ARDS, acute liver disease.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoSorbents Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: NY60273) on September 30, 2026, and is solely responsible for the information contained therein.